_______________________________________________________________________

          >>>   MEDSCAPE's Infectious Diseases MedPulse(R)   <<<

                          http://id.medscape.com

_______________________________________________________________________

 

ADVERTISEMENT

 

Register for an upcoming CME Satellite Symposium,

Emerging Trends in CMV Infection from HAART to Heart

Sunday, December 16, 2001, 6:30 - 9:00 am,

supported by Roche Pharmaceuticals, at the Chicago

Marriott Downtown, at the 41st Interscience Conferencehttp://hometown.aol.com/chevy974/myhomepagebaby.html

on Antimicrobial Agents and Chemotherapy (ICAAC)

 

For program description and registration, go to

http://www.cmv.icclink.com/register.html

 

           _____________________

 

ADVERTISEMENT

 

Announcing Evaluating the Future of Antiretroviral Therapy, Inside and Out,

USA. 16 December 2001

Get the latest information and register now for the CME certified Satellite

Symposium chaired by Michael Saag, MD, Sunday 16 December, 2001, 20.15 -

22.15 at the McCormick Place, Room E451, while attending the  41st

Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

Supported by an unrestricted educational grant from

Roche and Trimeris Pharmaceuticals. http://InsandOutsofHIV.com

 

_______________________________________________________________________

MedPulse is a weekly index of key news and features on Medscape's

specialty sites compiled by Medscape's Editors.

_______________________________________________________________________

___________________ NEW FEATURE ARTICLES THIS WEEK ____________________

 

-- MEDSCAPE ORIGINAL ARTICLES --

 

TALKING ABOUT BIOTERRORISM -

SMALLPOX: THE WEAPON THAT KNOWS NO BORDERS

Dr. Stanley Foster, a former smallpox 'warrior,' believes surveillance and

containment should be the main approach to preparedness.

Medscape Infectious Diseases, 2001

http://id.medscape.com/45817.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45817.rhtml?srcmp=id-120701"> Read it Here</a>

 

JOURNAL SCAN - INFECTIOUS DISEASES 4(12)

David Haburchak, MD, summarizes and comments on important new publications,

including:

- First Inhalational Anthrax Case Due to Bioterrorism

- Goal-directed Therapy of Sepsis

- Risk Index for Postoperative Pneumonia

- A Single Swab for Multiple STDs

- RSV and Influenza-like Illness

http://id.medscape.com/45903.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45903.rhtml?srcmp=id-120701"> Read it Here</a>

 

EDITORIAL - INNOVATIVE APPROACHES TO CERVICAL CANCER PREVENTION

Reducing cervical cancer deaths in developing countries will require new

preventive, public health approaches.

Medscape Women's Health 6(6), 2001

http://id.medscape.com/45833.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45833.rhtml?srcmp=id-120701"> Read it Here</a>

 

AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES 52ND ANNUAL MEETING

Leading authorities provide clinically focused and comprehensive updates on

topical issues in liver disease and its complications.

Medscape Gastroenterology 3(6), 2001. (C) 2001 Medscape, Inc.

http://id.medscape.com/45789.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45789.rhtml?srcmp=id-120701"> Read it Here</a>

 

FOCUS ON INFLUENZA

Coughing in Columbus, fever in Philadelphia, myalgia in Milwaukee --

where is influenza striking this week?  And what are the best

approaches to diagnosis, treatment, and prevention?  Find what

you are looking for in this collection of online resources available

on Medscape.  Get the latest information from the Web's most

trusted medical resource.

http://www.medscape.com/mp/rc/usmd/influenzone

 

-- CHEST 2001 --

 

UNDERSTANDING OF THE WEAPONS OF CHEMICAL/BIOLOGICAL TERRORISM IS THE KEY TO

BEING PREPARED

Are clinicians ready to treat patients exposed to bioterrorism?

Medscape, 2001. (C) 2001 Medscape, Inc.

http://id.medscape.com/45887.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45887.rhtml?srcmp=id-120701"> Read it Here</a>

 

UPDATE ON THE USE OF DROTRECOGIN ALFA (ACTIVATED) FOR THE TREATMENT OF  SEVERE SEPSIS

Will drotrecogin alfa (activated) emerge as a viable treatment for severe

sepsis?

Medscape, 2001. (C) 2001 Medscape, Inc.

http://id.medscape.com/45892.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45892.rhtml?srcmp=id-120701"> Read it Here</a>

 

CURRENT MANAGEMENT STRATEGIES FOR SEVERE SEPSIS AND SEPTIC SHOCK

R. Phillip Dellinger delivers the Roger C. Bone Memorial Lecture

Medscape, 2001. (C) 2001 Medscape, Inc.

http://id.medscape.com/45893.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45893.rhtml?srcmp=id-120701"> Read it Here</a>

 

CURRENT TRENDS IN MULTIDRUG-RESISTANT TUBERCULOSIS

What are the current treatment recommendations for multidrug-resistant

tuberculosis?

Medscape, 2001. (C) 2001 Medscape, Inc.

http://id.medscape.com/45894.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45894.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- MMWR: ANTHRAX --

 

UPDATE: INVESTIGATION OF BIOTERRORISM-RELATED INHALATIONAL ANTHRAX -- CONNECTICUT, 2001

The source of exposure to B. anthracis for the 94-year-old CT resident

remains unknown, but the genetic characteristics of the isolate links this

case with the previous bioterrorism-related cases.

MMWR 50(47):1049-1051, 2001. Centers for Disease Control

http://id.medscape.com/45800.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45800.rhtml?srcmp=id-120701"> Read it Here</a>

 

UPDATE: ADVERSE EVENTS ASSOCIATED WITH ANTHRAX PROPHYLAXIS AMONG POSTAL  EMPLOYEES --- NEW JERSEY, NEW YORK CITY, AND THE DISTRICT OF COLUMBIA METROPOLITAN AREA, 2001

Overall rates of adverse events are similar to the frequency of adverse

events among persons on ciprofloxacin therapy for any indication.

Discontinuation of therapy caused by adverse events was similar to other

groups previously studied.

MMWR 50(47):1051-1054, 2001. Centers for Disease Control

http://id.medscape.com/45801.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45801.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- MMWR --

 

SIMULTANEOUS ADMINISTRATION OF VARICELLA VACCINE AND OTHER RECOMMENDED CHILDHOOD VACCINES --- UNITED STATES, 1995--1999

No adverse effects have been reported of simultaneous administration of

DTP, Hib, MMR, and OPV on the immunogenicity of the varicella vaccine.

There is an increased risk for breakthrough disease in children who

received varicella vaccine <30 days after MMR, but not after the other

vaccines.

MMWR 50(47):1058-1061, 2001. Centers for Disease Control

http://id.medscape.com/45802.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45802.rhtml?srcmp=id-120701"> Read it Here</a>

 

HIV TESTING AMONG RACIAL/ETHNIC MINORITIES --- UNITED STATES, 1999

An estimated 300,000 HIV-infected persons in the United States may be

unaware of their HIV serostatus.

MMWR 50(47):1054-1058, 2001. Centers for Disease Control

http://id.medscape.com/45706.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45706.rhtml?srcmp=id-120701"> Read it Here</a>

 

WEEKLY UPDATE: WEST NILE VIRUS ACTIVITY ---UNITED STATES, NOVEMBER 14--20, 2001

Three human cases of WNV encephalitis or meningitis were reported from

Mass. (2) and NJ (1) this week.

MMWR 50(47):1061-1062, 2001. Centers for Disease Control

http://id.medscape.com/45707.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45707.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- EMERGING INFECTIOUS DISEASES --

 

CLINICAL CONSEQUENCES AND COST OF LIMITING USE OF VANCOMYCIN FOR

PERIOPERATIVE PROPHYLAXIS: EXAMPLE OF CORONARY ARTERY BYPASS SURGERY

Routine use of vancomycin for perioperative prophylaxis is discouraged,

principally to minimize microbial resistance to it.

Emerging Infectious Diseases 7(5), 2001

http://id.medscape.com/45835.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45835.rhtml?srcmp=id-120701"> Read it Here</a>

 

INTRAOPERATIVE REDOSING OF CEFAZOLIN AND RISK FOR SURGICAL SITE INFECTION IN CARDIAC SURGERY

Intraoperative redosing of prophylactic antibiotics is recommended for

prolonged surgical procedures, although its efficacy has not been assessed.

Emerging Infectious Diseases 7(5), 2001

http://id.medscape.com/45836.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45836.rhtml?srcmp=id-120701"> Read it Here</a>

 

PNEUMOCOCCAL SURFACE PROTEIN A OF INVASIVE STREPTOCOCCUS PNEUMONIAE

ISOLATES FROM COLOMBIAN CHILDREN

Streptococcus pneumoniae is a major respiratory pathogen that also causes

meningitis, otitis media, and bacteremia.

Emerging Infectious Diseases 7(5), 2001

http://id.medscape.com/45837.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45837.rhtml?srcmp=id-120701"> Read it Here</a>

 

EPIDEMIOLOGY OF AND SURVEILLANCE FOR POSTPARTUM INFECTIONS

The epidemiology of postpartum infections has not been well characterized.

Emerging Infectious Diseases 7(5), 2001

http://id.medscape.com/45838.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45838.rhtml?srcmp=id-120701"> Read it Here</a>

 

MOLECULAR IDENTIFICATION OF STREPTOMYCIN MONORESISTANT MYCOBACTERIUM TUBERCULOSIS RELATED TO MULTIDRUG-RESISTANT W STRAIN

With the advent of molecular techniques, TB investigators have a powerful

tool to further the understanding of the transmission and phylogenetic

properties of M. tuberculosis.

Emerging Infectious Diseases 7(5), 2001

http://id.medscape.com/45839.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45839.rhtml?srcmp=id-120701"> Read it Here</a>

 

EMERGING INFECTIOUS DISEASES IN AN ISLAND ECOSYSTEM: THE NEW ZEALAND PERSPECTIVE

Several unique features characterize infectious disease epidemiology in New

Zealand.

Emerging Infectious Diseases 7(5), 2001

http://id.medscape.com/45880.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45880.rhtml?srcmp=id-120701"> Read it Here</a>

 

CHANGING EPIDEMIOLOGY OF Q FEVER IN GERMANY; 1947-1999

The epidemiology of Q fever in Germany was examined by reviewing relevant

studies since 1947 and by analyzing available surveillance data since 1962.

Emerging Infectious Diseases 7(5), 200

http://id.medscape.com/45881.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45881.rhtml?srcmp=id-120701"> Read it Here</a>

 

FIRST ISOLATION OF LA CROSSE VIRUS FROM NATURALLY INFECTED AEDES ALBOPICTUS

La Crosse virus, a California serogroup bunyavirus, is the leading cause of

pediatric arboviral encephalitis in the United States.

Emerging Infectious Diseases 7(5), 2001

http://id.medscape.com/45883.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45883.rhtml?srcmp=id-120701"> Read it Here</a>

 

FACTORS CONTRIBUTING TO THE EMERGENCE OF ESCHERICHIA COLI O157 IN AFRICA

In 1992, a large outbreak of bloody diarrhea caused by E. coli O157

infections occurred in southern Africa.

Emerging Infectious Diseases 7(5), 2001

http://id.medscape.com/45884.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45884.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- INFECTIONS in MEDICINE: VACCINE ISSUE --

 

VACCINES IN THE 21ST CENTURY

New concepts in vaccination, including recombinant subunits, reassortment

virus techniques, live vectors, and naked DNA technology, are just over the

horizon.

http://id.medscape.com/45748.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45748.rhtml?srcmp=id-120701"> Read it Here</a>

 

CURRENT ADULT AND PEDIATRIC VACCINE RECOMMENDATIONS

More than 40,000 lives would be saved each year in the US if routine

vaccines against pneumococcal infection, influenza, and hepatitis B were

fully utilized.

http://id.medscape.com/45749.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45749.rhtml?srcmp=id-120701"> Read it Here</a>

 

IMMUNIZATIONS INVOLVED WITH INTERNATIONAL ADOPTION AND TRAVEL

Preparation for international adoption should include a detailed pretravel

assessment of the immunization status of the adopting family, and the

immunization status of foreign-born children should be reviewed and updated

shortly after their arrival.

http://id.medscape.com/45750.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45750.rhtml?srcmp=id-120701"> Read it Here</a>

 

VACCINES IN THE PIPELINE -- AN OVERVIEW

Vaccines in developent include those against CMV, group B streptococci,

HIV, hepatitis C, rotavirus, pertussis in adolescents and adults, human

papillomavirus, genital herpes, tuberculosis, malaria, serotype B

meningococci, and multidrug-resistant staphylococci.

http://id.medscape.com/45751.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45751.rhtml?srcmp=id-120701"> Read it Here</a>

 

COST-EFFECTIVENESS OF A POTENTIAL VACCINE FOR COCCIDIOIDES IMMITIS

Vaccination of children in highly endemic regions would provide a large

health benefit and would reduce total health care expenditures.

http://id.medscape.com/45882.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45882.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- OTHER JOURNALS --

 

CURRENT TREATMENT CONSIDERATIONS IN COMMUNITY-ACQUIRED PNEUMONIA IN OLDER  PATIENTS

The incidence of community-acquired pneumonia increases markedly in older

individuals, among whom the principal risk factor for CAP is chronic

underlying disease.

Drug & Ther Perspect 17(21):5-8, 2001

http://id.medscape.com/45785.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45785.rhtml?srcmp=id-120701"> Read it Here</a>

 

FIRST REPORTS OF ADVERSE DRUG REACTIONS (ADRS) IN RECENT WEEKS

Reports of ADRs to amoxicillin/clavulanate, antiretrovirals, and quinolones.

Drug & Ther Perspect 17(21):15, 2001

http://id.medscape.com/45788.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45788.rhtml?srcmp=id-120701"> Read it Here</a>

 

LOPINAVIR-RITONAVIR: A NEW PROTEASE INHIBITOR

The exact resistance patterns of lopinavir-ritonavir are unknown, but the

HHS strongly recommends it for the initial treatment of HIV-infected adults

and adolescents.

Pharmacotherapy 21(11):1352-1363, 2001

http://id.medscape.com/45790.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45790.rhtml?srcmp=id-120701"> Read it Here</a>

 

HIV-ASSOCIATED WASTING IN THE ERA OF HAART: A PRACTICE-BASED APPROACH TO

DIAGNOSIS AND TREATMENT

Malnutrition, weight loss, and wasting have remained hallmarks of HIV

disease since the beginning of the AIDS epidemic.

The AIDS Reader 11(11):557-560, 566-569, 2001

http://id.medscape.com/45824.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45824.rhtml?srcmp=id-120701"> Read it Here</a>

 

TRACHEOESOPHAGEAL FISTULA AND MASSIVE PNEUMOPERITONEUM AFTER PROLONGED MECHANICAL VENTILATION

Tracheoesophageal fistula is one of the uncommon but serious sequelae of

endotracheal intubation.

South Med J 94(10):1027-1029

http://id.medscape.com/45831.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45831.rhtml?srcmp=id-120701"> Read it Here</a>

 

TODAY'S QUESTION --

 

TODAY'S ?? - ANTHRAX PROPHYLAXIS AND BREASTFEEDING

What is the recommended antimicrobial prophylaxis for breastfeeding mothers

with suspected anthrax exposure?

http://id.medscape.com/45904.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45904.rhtml?srcmp=id-120701"> Read it Here</a>

 

 

_______________________________________________________________________

___________________________________ NEWS ______________________________

 

-- BIOTERRORISM --

 

TRACES OF ANTHRAX FOUND IN A CONNECTICUT LETTER

Trace amounts of anthrax, that could have resulted from cross

contamination, were found in a letter sent to a Connecticut family that

lived near a 94-year-old woman who died of anthrax earlier this month,

Connecticut officials said on Friday.

http://id.medscape.com/45698.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45698.rhtml?srcmp=id-120701"> Read it Here</a>

 

AMA WANTS MORE STUDY OF MASS SMALLPOX VACCINATION; RESCINDS MANDATORY HIV TESTING IN PREGNANCY

The American Medical Association's House of Delegates voted Tuesday to take

a cautious approach to a national smallpox vaccination program, urging the

federal government to wait for good science before ordering universal

vaccinations.

http://id.medscape.com/45872.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45872.rhtml?srcmp=id-120701"> Read it Here</a>

 

PUBLIC INFORMATION WILL BE KEY TO EFFECTIVE BIOTERRORISM RESPONSE

The primary defense against the spread of smallpox or other infectious

agent used in a bioterrorist attack should not involve a large-scale

quarantine of potentially exposed individuals, as some emergency management

personnel have proposed, US researchers assert.

http://id.medscape.com/45873.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45873.rhtml?srcmp=id-120701"> Read it Here</a>

 

HOUSE MEMBERS UNVEIL BIPARTISAN BIOTERRORISM BILL

The House could vote as soon as next week on a comprehensive, bipartisan

bill aimed at improving the nation's preparedness for biological or

chemical attacks.

http://id.medscape.com/45923.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45923.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- EBOLA VIRUS --

 

MYSTERIOUS ILLNESS KILLS SIX IN GABON'S EBOLA ZONE

Six people have died of a mysterious illness in a part of Gabon where the

Ebola virus killed at least 66 people in 1996, the country's health

minister said on Wednesday.

http://id.medscape.com/45858.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45858.rhtml?srcmp=id-120701"> Read it Here</a>

 

HIV AND EBOLA SHARE SAME MECHANISM FOR BUDDING FROM INFECTED CELLS

HIV and Ebola virus both recruit the Tsg101 protein from infected cells to

complete their budding process, investigators from the Aaron Diamond AIDS

Research Center in New York report in the December issue of Nature Medicine.

http://id.medscape.com/45705.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45705.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- BSE/CJD --

 

RISK OF BOVINE SPONGIFORM ENCEPHALOPATHY LOW IN US

The USDA said Friday that a recent study found little risk of bovine

spongiform encephalopathy in US cattle.

http://id.medscape.com/45697.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45697.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- HIV/AIDS --

 

UNIVERSAL HIV SCREENING AT AMSTERDAM STD CLINIC APPEARS TO BE COST-EFFECTIVE

In the Netherlands, at least, screening all attendees at an STD clinic for

HIV infection appears to be cost-effective, based on the costs of other

infectious disease control measures.

http://id.medscape.com/45724.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45724.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- INFLUENZA --

 

APOPTOTIC INFLUENZA PROTEIN MAY TARGET IMMUNE CELLS

A newly discovered protein, PB1-F2, encoded by influenza A virus, prompts

apoptosis and may serve to kill immune cells, according to researchers in

the US and Germany.

http://id.medscape.com/45745.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45745.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- TUBERCULOSIS --

 

SERIOUS TB SPECIALIST SHORTAGE SEEN IN UK

The UK is 'desperately' short of staff to monitor and treat the growing

number of tuberculosis cases, the British Thoracic Society warned at its

winter meeting in London on Wednesday.

http://id.medscape.com/45777.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45777.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- MEASLES --

 

EARLY TWO-DOSE MEASLES VACCINATION DEEMED USEFUL IN ENDEMIC AREAS

An early two-dose measles vaccination schedule can improve vaccination

coverage in areas at high risk of measles among infants, according to an

analysis of the schedule's impact in Dade County, Florida.

http://id.medscape.com/45778.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45778.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- DRUG APPROVALS --

 

LANNETT WINS APPROVAL FOR GENERIC ISONIAZID

Generic drugmaker Lannett Company Inc. said on Tuesday that it has received

approval from the US FDA to market a 300-mg tablet formulation of isoniazid.

http://id.medscape.com/45780.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45780.rhtml?srcmp=id-120701"> Read it Here</a>

 

BAYER WINS FDA APPROVAL FOR INTRAVENOUS AVELOX

Bayer Corporation said on Tuesday that it has received approval from the

FDA to market an intravenous formulation of Avelox (moxifloxacin), a

broad-spectrum antibiotic in the same class as the firm's Cipro

(ciprofloxacin).

http://id.medscape.com/45781.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45781.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- FUNGAL INFECTIONS --

 

FLUCONAZOLE PROPHYLAXIS PREVENTS FUNGAL INFECTIONS IN PRETERM INFANTS

When given during the first 6 weeks of life, fluconazole effectively

prevents fungal colonization and invasive fungal infections in extremely

low-birthweight infants, according to a report in the December 6th issue of

the New England Journal of Medicine.

http://id.medscape.com/45847.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45847.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- MALARIA --

 

GLAXOSMITHKLINE MALARIA VACCINE SAFE AND EFFECTIVE

RTS,S/AS02 (GlaxoSmithKline Biologicals, Rixensart, Belgium) is the first

pre-erythrocytic malaria vaccine to offer significant protection for

semi-immune adults exposed to natural infection, according to results from

a randomized trial conducted in The Gambia.

http://id.medscape.com/45917.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45917.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- INFECTIONS in ONCOLOGY --

 

PACLITAXEL USE BY BREAST CANCER PATIENTS TIED TO PNEUMONITIS AFTER RADIOTHERAPY

Breast cancer patients treated with paclitaxel and radiation therapy (RT)

are much more likely to develop pneumonitis than similar patients treated

with a different chemotherapeutic agent, according to a report published in

the December 5th issue of the Journal of the National Cancer Institute.

http://id.medscape.com/45761.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45761.rhtml?srcmp=id-120701"> Read it Here</a>

 

-- OTHER ID NEWS --

 

SURGEON GENERAL CALLS CDC'S ATLANTA LABS A NATIONAL DISGRACE

US Surgeon General Dr. David Satcher said Monday that the United States

should be 'ashamed of the condition of the laboratories at the Centers for

Disease Control and Prevention in Atlanta.'

http://id.medscape.com/45742.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45742.rhtml?srcmp=id-120701"> Read it Here</a>

 

GROUP A STREP BINDS CD44 TO OPEN TIGHT EPITHELIAL JUNCTIONS, INVADE TISSUE

The invasive nature of group A streptococcus appears to derive from the

binding of the bacteria's hyaluronic acid capsular polysaccharide and CD44,

the hyaluronic acid-binding protein on epithelial cells.

http://id.medscape.com/45878.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45878.rhtml?srcmp=id-120701"> Read it Here</a>

 

HIGH CONSUMPTION OF ASTHMA MEDICATION LINKED TO HIGHER RATE OF ANTIBIOTIC USE

Researchers in Boston have disproved their own hypothesis that underuse of

anti-inflammatory medications by asthmatics is related to overprescription

of antibiotics.

http://id.medscape.com/45906.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45906.rhtml?srcmp=id-120701"> Read it Here</a>

 

CDC REPORTS FOUR CASES OF SEPTIC ARTHRITIS AFTER ACL RECONSTRUCTION

Four patients undergoing anterior cruciate ligament (ACL) reconstruction in

Florida and Louisiana last year acquired septic arthritis, probably due to

contaminated bone-tendon-bone allografts, according to the CDC.

http://id.medscape.com/45932.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45932.rhtml?srcmp=id-120701"> Read it Here</a>

 

BACTERIOPHAGE ENZYME RAPIDLY KILLS STREPTOCOCCUS PNEUMONIAE

In a mouse model, researchers have demonstrated that a bacteriophage lytic

enzyme, called Pal, kills 15 types of Streptococcus pneumoniae on contact.

http://id.medscape.com/45936.rhtml?srcmp=id-120701

<a href="http://id.medscape.com/45936.rhtml?srcmp=id-120701"> Read it Here</a>

 

_______________________________________________________________________

_____________________________ MEMBER NEWS _____________________________

 

**NEW MEDPULSE NEWSLETTERS**

Interested in hearing about all of the upcoming CME programs related to

your specialty? Medpulse has them. Log on to

http://www.medscape.com/mp/updateprofile , scroll down to Medpulse

Preferences and choose from over 30 customized by specialty newsletters.

Here are some of our more popular newsletters:

 

ALLERGY

CARDIOLOGY

CRITICAL CARE

HEMATOLOGY

HIV/AIDS

INTERNAL MEDICINE

PEDIATRICS

PSYCHIATRY

SURGERY

Go to http://www.medscape.com/mp/updateprofile

and review our full list of available newsletters.

 

 

NO MORE JUNK E-MAIL........

http://www.medscape.com/medscapemail

Sign up for a private e-mail account on Medscape.com. Medscape Mail allows

you to:

 

-Apply rules to automatically delete undesired E-mails so NO MORE JUNK

MAIL!

-Be alerted when new messages arrive in your inbox

-Automatically alert patients and colleagues as to when you are out of the

office or on vacation and when you will be returning.

 

Plus, while you're checking your e-mail every day, you can visit Medscape

Today to read the day's latest medical headlines. Or visit our CME Center

to learn what new programs were added for your specialty. To create your

free e-mail account, just point your browser to

http://www.medscape.com/medscapemail

 

 

_______________________________________________________________________

_____________________________ USER SUPPORT ____________________________

 

Unsubscribe or subscribe to MedPulse: http://www.medscape.com/profile

(<A HREF=" http://www.medscape.com/profile">Edit Your Profile</A>).

 

Forgot your login info?:  http://www.medscape.com/password

(<A HREF=" http://www.medscape.com/password">Get Your Account Info</A>)

to retrieve your account information.

 

Need additional support?: http://www.medscape.com/help/tech

(<A HREF=" http://www.medscape.com/help/tech">Technical Support</A>)

 

 

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.